NCT02616822View on ClinicalTrials.gov

Effects of Trans-Resveratrol in Endothelial Function in Hypertensive Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Endothelial Dysfunction
Interventions
DIETARY_SUPPLEMENT

Trans-resveratrol

Used for trans-resveratrol substance 300 mg single dose

OTHER

Placebo

Used for placebo substance single dose

All Listed Sponsors
lead

Hospital Universitario Pedro Ernesto

OTHER

NCT02616822 - Effects of Trans-Resveratrol in Endothelial Function in Hypertensive Patients | Biotech Hunter | Biotech Hunter